The pancreatic P-and a-cells are developmentally related to each other but reveal diverse gene expression patterns. Among the two important transcription factors for insulin gene expression, IEF1 is present both in a-and p-cells, but PDX-1/IPF1/STF-1/IDX-1, a homeodomain-containing transcription factor, is present in P-cells but not in a-cells. To elucidate the function of PDX-1 in the expression of P-cell-specific genes, we established stable aTCl clone 6 (aTC1.6)-derived transfectants expressing PDX-1 and examined the changes in the gene expression patterns in them. The exogenous expression of PDX-1 in aTCl.6 cells alone could induce islet amyloid polypeptide (IAPP) mRNA expression in the cells but not the expression of insulin, glucokinase, or GLUT2 gene. However, when betacellulin was added to the medium, the PDX-1-expressing aTCl.6 cells, but not the control aTCl.6 cells, came to express insulin and glucokinase mRNAs. This did not occur with other growth factors such as epidermal growth factor, transforming growth factor a, and insulin-like growth factor I. GLUT2 mRNA remained undetectable in the PDX-1-expressing aTCl.6 cells. These observations demonstrate the potency of PDX-1 for the expression of the insulin, glucokinase, and IAPP genes and suggest that certain regulatory factors, which can partially be modified by betacellulin, also contribute to the p-cell specificity of gene expression.
E ndocrine cells of the adult pancreas are organized into islets of Langerhans which are scattered throughout the exocrine tissue. There are four major islet cell types, a-, (3-, 8-, and pp-cells, which synthesize glucagon, insulin, somatostatin, and pancreatic polypeptide, respectively. Although the cell lineage relationship of the different islet cells has not yet been fully elucidated, the coexpression of several polypeptide hormones in a single cell has been detected during the embryonic development of the pancreas (1) . Also, some cloned cell lines derived from islet cell tumors have been shown to express multiple pancreatic hormones (2) . These findings suggest that the development of endocrine cells starts with a common precursor and that the terminal differentiation leading to the expression of one hormone in each islet cell type occurs late in development. This, in turn, implies that the various islet cell types may share a set of transcriptional regulatory proteins and that selective expression of hormone genes in the fully differentiated islet cells may be regulated by only a small number of cell type-specific discriminatory proteins. Identifying such proteins would be essential in understanding fully the development of the endocrine pancreas.
The (3-cell-specific expression of insulin genes has been shown to be dependent on cis-acting elements located in the 5'-flanking sequence (3) . Two cis-acting motifs, E and A elements, and their binding transcription factors play a primary role in generating strong promoter activity of the insulin genes in p-cells (4, 5) . The E elements, which can be classified, in a broad sense, as an E box (6) , bind IEF1, a transcription factor complex composed of two different helix-loop-helix proteins, in (3-cells (7) . IEF1 cannot be identified in most of the non-3-cell tissues or cells, but is present in a-cell-derived a-tumor cell 1 clone 6 (aTC1.6) cells (8) , and thus is unlikely to be involved in the differentiation between a-and p-cells. The A elements, on the other hand, are known as binding sites for a group of proteins that belong to the homeodomain family of transcription factors (9, 10) . Among the A-element-binding proteins, the one with the evident physiological significance is the homeodomain-containing transcription factor PDX-1, in mouse originally isolated as IPF1 (10) and in rat as STF-l/IDX-1 (11, 12) . PDX-1 appears before insulin during the ontogeny of the mouse pancreas and its expression eventually becomes restricted to the p-cells in the adult (10) (11) (12) (13) .
To elucidate the role of PDX-1 in the (3-cell-specific gene expression, we introduced PDX-1 expression into aTC1.6 cells and examined the changes in the gene expression pattern. aTC1.6 cells were originally isolated from aTCl cells, an a-cell-derived multiclonal cell line established using a transgene strategy (14) . Although the original aTCl cells were composed of heterologous cell populations that seem to correspond to a-cells and their progenitors, the aTCl.6 clone totally lacked insulin mRNA and thus was similar to the differentiated a-cells in vivo (14) . We report here that PDX-1 exogenously expressed in aTCl.6 cells could contribute to the expression of three (3-cell specific genes: islet amyloid polypeptide (IAPP), insulin, and glucokinase. However, in support of the complexity of the mechanisms underlying (3-cell specificity in gene expression, we found that, for insulin and glucokinase gene expression in these cells, they also had to be treated with the epidermal growth factor (EGF)-family growth factor betacellulin.
RESEARCH DESIGN AND METHODS

Materials.
Human transforming growth factor (TGF)-a and EGF were obtained from Wakunaga Pharmaceutical Co. (Hiroshima, Japan), human IGF-I from Fujisawa Pharmaceutical Co. (Osaka, Japan), human basic fibroblast growth factor (bFGF) from Upstate Biotechnology, Inc. (Lake Placid, NY), and human TGF-(3 from King Brewing Inc. (Kakogawa, Japan). Human betacellulin was a kind gift from Dr. R. Sasada (Takeda Chemical Industries, Ltd.). The sources of the other materials have been described previously (15) . Basic laboratory procedures were performed according to standard protocols (16) , unless otherwise stated. Cell culture. The a-cell-derived cell line aTCl.6 cells and (3-cell-derived tumor cell 1 (|BTC1) cells were grown in RPMI-1640 medium, supplemented with 10% heat-inactivated fetal bovine serum, penicillin, and streptomycin. To investigate the effects of growth factors on mRNA expressions, the growth factors were individually added to the RPMI-1640 medium described above, and the cells were cultured for 4 days. Preparation of stable transfectants. For the generation of stable transfectants, aTCl.6 cells were replated in 10-cm plates 24 h before transfection. Ten micrograms of the PDX-1 expression plasmid, pcDNA3-IPFl (15), and 2 ug pBluescript II (Stratagene, San Diego, CA) plasmid were cotransfected into the cells by the lipofection method using lipofectAMINE reagent (Life Technologies, Tokyo, Japan) under the conditions recommended by the manufacturer. Forty-eight hours after lipofection, the cells were transferred to G418-containing medium (600 ug/ml; Sigma, St. Louis, MO). G418-resistant colonies appeared 4 weeks after lipofection, and positive clones were subcloned and used for further analyses. Northern blot analyses. Northern blots followed standard procedures using 1 ug poly(A) + RNA (16) . A mouse PDX-1 cDNA (nucleotides 772-1134) (10) was prepared using reverse transcription-polymerase chain reaction (RT-PCR) and subcloned into the pBluescript II plasmid. The plasmid pMIn2C containing a mouse insulin II cDNA was a generous gift from Drs. J.M. Chirgwin and M.A. Permutt. Western blot analyses. Western blots for the detection of PDX-1 were performed as described previously (15), using 10 ug of nuclear extracts. Gel mobility-shift analyses. The binding reactions were performed as described by German et al. (17), using 5 ug of each nuclear extract. In some of the binding assays, 2 ul preimmune serum or anti-PDX-l(IPFl) antiserum (15) was added to the binding reactions 30 min before the addition of the DNA probes. The samples were fractionated on a 5% polyacrylamide gel that was precooled to 4°C in 0.5 x TBE (45 mmol/1 Tris base, 45 mmol/1 boric acid, 1 mmol/1 EDTA). RT-PCR analyses. Using 1 ug of the total RNA as a template and a set of antisense oligonucleotides complementary to each mRNA, the first cDNA strands were reverse-transcribed in 30 pi of a reaction mixture containing reagents recommended by the supplier (Takara, Kyoto, Japan). For the subsequent PCR, 1 ul of the reaction mixture was used each time. Oligonucleotide primers used for the amplification of p-actin, insulin, glucokinase, and GLUT2 mRNAs were described previously (18) . Oligonucleotides used for glucagon and IAPP mRNAs were all synthesized as 20mers and the nucleotide numbers of the 5' end of primers used for the reverse transcription were 332 (19) and 543 (20) , respectively. Those for the PCR primers for glucagon cDNA were -4 and 245 (19) , and those for IAPP were 252 and 488 (20) . The PCR conditions used were denaturation at 94 G C for 1.5 min, annealing at 56°C for 1.5 min, and extension at 72°C for 1.5 min. The number of PCR cycles for pactin cDNA amplifications was 31, that for glucagon and insulin was 33, and that for glucokinase and GLUT2 was 36. The PCR products were separated on an agarose gel and visualized with ethidium bromide.
RESULTS
Functional expression of PDX-1 in aTCl.6 stable transfectants. By examining G418-resistant clones by RT-PCR in terms of expression of PDX-1 mRNA (data not shown), we isolated two clones, clone PDX(+)aTC1.6, which expressed PDX-1 mRNA abundantly, and clone PDX(-)aTC1.6, in which PDX-1 mRNA was not detected. The exogenously introduced PDX-1 mRNA in PDX(+)aTC1.6 cells was detectable also in Northern blot analysis as a single 1.8-kb band (Fig. 1) . Although the amount of PDX-1 mRNA expressed in PDX(+)aTC1.6 cells was greater than the total of two PDX-1 gene transcripts (2.3 and 6.4 kb) expressed in (3TC1 cells, the amount of PDX-1 protein in PDX(+)aTC1.6 was less than that in (3TC1 cells (Fig. 2) . No PDX-1 mRNA or protein was detectable in PDX(-)aTC1.6 c e n s (Figs. 1 and 2 ), being consistent with the RT-PCR results. To examine whether PDX-1 exogenously expressed in aTC1.6 cells functions properly, the DNA-binding activity of PDX-1 was evaluated in gel-mobility shift assays using the human insulin gene A3 (hInsA3) element (21) as a probe. As shown in Fig. 3 , a major DNA-protein complex was formed with the hInsA3 probe and the nuclear extract of (3TC1 cells, and the band was supershifted in the presence of anti-PDX-l(IPFl) antiserum. A band with the same mobility was present in PDX(+)aTC1.6 but not in PDX(-)aTC1.6 (Fig. 3) . The intensity of the band for PDX(+)aTC1.6 was weaker than that for (3TC1 (Fig. 3) in accordance with the similar observation in the Western blot analysis (Fig. 2) . These results demonstrated that PDX-1 introduced and expressed in aTC1.6 cells functions properly at least in terms of the DNA binding activity to the hInsA3 element. We also performed a gel mobility-shift analysis using a probe reproducing the human insulin gene E element (21) and identified a single band of identical mobility, presumably IEF1, for PDX(-)aTC1.6, PDX(+)aTC1.6, and pTCl cells (data not shown). IAPP gene expression identified in PDX(+)aTC1.6. Changes in gene expression patterns caused by exogenous PDX-1 expression in aTC1.6 cells were investigated. Messenger RNA expressions for insulin, glucagon, IAPP, glucokinase, GLUT2, and (3-actin genes were examined by RT-PCR analyses. As shown in Fig. 4 , glucagon mRNA was detectable in parental aTCl.6, PDX(-)aTC1.6, and PDX(+)aTC1.6 cells. The amounts also seemed similar in PDX(-)aTC1.6 and PDX(+)aTC1.6 cells according to Northern blot analysis (data not shown). On the other hand, IAPP mRNA was detectable only in PDX(+)aTC1.6 cells and not in parental aTC1.6 and PDX(-)aTC1.6 cells (Fig. 4) . No mRNA for the other p-cell-specific genes, such as insulin, glucokinase, or GLUT2 gene, was detectable in parental aTC1.6, PDX(-)aTC1.6, and PDX(+)aTC1.6 cells (Fig. 4) . Insulin gene expression in PDX(+)aTC1.6 cells induced N by betacellulin. The possible involvement of various growth factors in pancreas development has been suggested (22) . We next examined the possibility that some growth factors induce changes in the cell that affect the expression of P-cell-specific genes. The effects of TGF-a, TGF-p, betacellulin, EGF, IGF-I, and bFGF on the intrinsic insulin gene expression in PDX(+)aTC1.6 and PDX(-)aTC1.6 cells were evaluated. As shown in Fig.  5 , the addition of betacellulin to the medium induced insulin gene expression in PDX(+)aTC1.6 cells. This induction was not observed when betacellulin was added to PDX(-)aTC1.6 (Fig. 5) or parental aTC1.6 cells (data not shown). Other growth factors had no such gene-activating effect on PDX(+)aTC1.6 or PDX(-)aTC1.6 cells (Fig. 5) . In terms of the quantity of gene expression, the amount of insulin mRNA in betacellulin-treated PDX(+)aTC1.6 cells remained considerably lower than that in pTCl cells as judged by the results of Northern blotting analysis (data not shown). We then examined the effects of betacellulin on the expression of other (B-cell-specific genes. Similar to our observation with the insulin gene, the addition of betacellulin caused glucokinase gene expression only in PDX(+)aTC1.6 but not in parental aTCl.6 or PDX(-)aTC1.6 cells (Fig. 6) . IAPP mRNA, which was already detectable in PDX(+)aTC1.6 cells before the addition of betacellulin, remained there. In contrast, GLUT2 mRNA remained undetectable in parental aTCl.6, PDX(-)aTC1.6, and PDX(+)aTC1.6 cells, regardless of the addition of betacellulin (Fig. 6 ).
DISCUSSION
The homeodomain-containing transcription factor PDX-1 was originally isolated as a binding factor for the A elements of the insulin gene. However, sequences similar to these A elements have been identified in the glucokinase and IAPP genes, suggesting their involvement in activating these genes (15, 17) . Also, the phenotype of the previously described PDX-l(IPFl)-knock-out mouse showed not the simple loss of insulin synthesis but loss of the entire pancreas (23) . These observations suggest that the actual roles of PDX-1 are more extensive than originally expected for an insulin gene transcription factor. In this study, we sought to evaluate the potential function of PDX-1 by examining its effects on the endogenous mRNA expression in a-cell-derived aTCl.6 cells. Our results revealed that PDX-1 expression in the cells is relevant to the expression of at least three genes that are not expressed in the original aTCl.6 cells: insulin, glucokinase, and IAPP genes (Figs. 4-6 ). While these three genes commonly contain the A elements or homologous sequences in their regulatory regions, PDX-1 did not induce the expression of GLUT2 gene (Figs. 4 and 6) , which lacks the A element-like region (24), thus supporting the idea that PDX-1 activation of the transcription of these p-cell-specific genes is mediated by A element-like sequences.
Various growth factors have been suggested to be involved in the development of the endocrine pancreas (22, 25) . Among those, betacellulin was originally identified and cloned from the conditioned medium of (Bcell-derived (3TC3 cells as a growth-promoting factor having structural characteristics of the EGF-family members (26). Along with a wide variety of tissues, including kidney, lung, and vascular smooth muscle cells, pancreatic islet cells in vivo also express betacellulin (27) . Recently, we have reported, in collaboration with others, that betacellulin with the aid of activin A could convert some populations of polyclonal AR42J cells into insulinsecreting cells (25) . AR42J cells are derived from a chemically induced pancreatic tumor and possess both exocrine and neuroendocrine properties. In the present study, betacellulin was shown to be potent for inducing RT-PCR analyses were performed using total RNA isolated from PDX(-)aTC1.6 (lanes 1, 3, 5, 7, 9, 11, and 13} and PDX(+)otTC1.6 (lanes 2, 4, 6, 8, 10, 12, and 14} 13 and 14) . The upper panel shows the results for insulin mRNA and the lower panel, for P-actin mRNA. The expected sizes of amplified cDNAs were 339 and 250 bp, respectively. The primers used in these experiments were described previously (18) . The same results were obtained in two independent experiments. endogenous insulin and glucokinase gene expressions in PDX-1-expressing aTC1.6 cells (Figs. 5 and 6 ). Functioning as an inducer of (3-cell-specific gene expressions in at least two in vitro cell systems, betacellulin is likely to play a physiological role in 3-cell development in vivo. It remains to be clarified what kind of specific changes betacellulin caused in the aTC1.6 cells in order to prepare them for the PDX-1-responsive induction of insulin and glucokinase gene expressions. As with many other genes, mRNA expression of the insulin gene seems to be under the control of transcriptional and posttranscriptional regulations (28) . In terms of the former, some unidentified transcription factors, such as RIPE3bl protein (21) and the negative regulator of transcription (29) , have also been suggested to be involved in insulin gene regulation. Betacellulin may modify the activity of those transcription factors and contribute toward activating the insulin gene promoter in PDX-1-expressing aTC1.6 cells. On the other hand, the methylation and demethylation of chromosomal DNA has recently been suggested as being important to transcriptional regulation, especially in determining tissue specificity of gene expression (30) . Further, Szyf et al. (31) recently showed that the intracellular signaling molecule RAS, an important signal transducer for tyrosine kinase-type receptors, including the EGF receptor family, activates general DNA demethylation activity. These support the possibility that betacellulin may cause the demethylation of chromosomal DNA to release the insulin gene promoter from inactivation. While the stability of some mRNAs seems to be modified by growth factors such as EGF (32) , it is also possible that posttranscriptional regulation can partly explain the phenomenon. Studying these issues using the PDX-1-expressing aTC1.6 cell system or another may provide a useful clue to understanding the mechanism underlying the p-cell-specific regulation of insulin or glucokinase gene.
PDX-1-INDUCED
Betacellulin binds to the EGF receptor, and its growthpromoting action in fibroblasts is believed to be exerted through the EGF receptor (33) . However, Riese et al. (34) has recently shown that betacellulin activates erbB-4 and the EGF receptor and induces cellular response patterns distinct from those stimulated by EGF. The difference we found in the effects between betacellulin and other EGFfamily growth factors on the gene expression patterns of PDX(+)aTC1.6 cells (Fig. 5) supports the existence of a receptor for betacellulin other than the EGF receptor, possibly erbB-4, in the aTC1.6 cells.
Unlike insulin and glucokinase genes, the induction of IAPP did not require the presence of betacellulin (Fig. 4) . The IAPP gene is expressed in a relatively wide range of tissues when compared with the insulin or glucokinase gene. IAPP is detectable in (3-and 8-cells in pancreatic islets (35) , stomach, duodenum, and jejunum (36) . This tissue distribution pattern is similar to that of PDX-1, reported previously (10) . Also, the coexpression of PDX-1 and IAPP was identified in an glucagon-producing cell line, NHI-6F-GLU (37). These observations, including ours, agree with the idea that the presence of PDX-1 per se primarily determines the expression of IAPP gene.
The mRNA amounts of insulin, glucokinase, and IAPP gene remained low in the PDX-1-expressing aTC1.6 cells. Because the PDX(+)aTC1.6 cells contained PDX-1 and IEF1 DNA-binding activities that were comparable with those in [3TC1 cells (Fig. 3 and data not shown) , it is likely that, even after the betacellulin treatment, one or more factors required for the full activation of the insulin gene may be missing or very weakly functioning in PDX(+)aTC1.6 cells.
In conclusion, our present observations demonstrate the potency of PDX-1 for the expression of (3-cell-specific genes and also support the involvement of other factors that can, in part, be modified by betacellulin.
